0000950170-24-077346.txt : 20240625 0000950170-24-077346.hdr.sgml : 20240625 20240625163822 ACCESSION NUMBER: 0000950170-24-077346 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240621 FILED AS OF DATE: 20240625 DATE AS OF CHANGE: 20240625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mathers Edward T CENTRAL INDEX KEY: 0001328625 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38223 FILM NUMBER: 241069435 MAIL ADDRESS: STREET 1: C/O MEDIMMUNE, INC. STREET 2: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001649904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 462159271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-264-4280 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: RHYTHM METABOLIC, INC. DATE OF NAME CHANGE: 20150803 4 1 ownership.xml 4 X0508 4 2024-06-21 0001649904 RHYTHM PHARMACEUTICALS, INC. RYTM 0001328625 Mathers Edward T 104 5TH AVE NEW YORK NY 10011 true false false false false Common Stock 2024-06-21 4 M false 3000 A 3000 D Common Stock 5771 I See Note 2 Restricted Stock Units 2024-06-21 4 M false 3000 0 D Common Stock 3000 0 D Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The Reporting Person is the trustee of the Edward Timothy Mathers Revocable Trust (the "Mathers Trust"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest. The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date. /s/ Zachary Bambach, attorney-in-fact 2024-06-25